Redcare Pharmacy NV (XSWX:RDC) 3-Year RORE % : 28.62% (As of Mar. 2026)


XSWX:RDC Redcare Pharmacy NV XSWX:RDC
48 GF Score
Price CHF60.95
GF Value CHF143.20
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV 3-Year RORE %?

Redcare Pharmacy NV XSWX:RDC 48 3-Year RORE % is 28.62 as of Mar. 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks better than 76.77% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Redcare Pharmacy NV's 3-Year RORE % for the quarter that ended in Mar. 2026 was 28.62%.

The industry rank for Redcare Pharmacy NV's 3-Year RORE % or its related term are showing as below:

XSWX:RDC's 3-Year RORE % is ranked better than
76.77% of 607 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs XSWX:RDC: 28.62

Redcare Pharmacy NV  (XSWX:RDC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Redcare Pharmacy NV 3-Year RORE % Related Terms


Redcare Pharmacy NV 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV 3-Year RORE % Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.23 31.59 -40.20 -30.62 25.01

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.54 -17.32 20.29 25.01 28.62

Redcare Pharmacy NV 3-Year RORE % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redcare Pharmacy NV 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's 3-Year RORE % falls into.


XSWX:RDC
48GF Score
Redcare Pharmacy NV XSWX:RDC
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV 3-Year RORE % Calculation

Redcare Pharmacy NV's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -1.721--0.449 )/( -4.444-0 )
=-1.272/-4.444
=28.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 28.62 mean?
Redcare Pharmacy NV (XSWX:RDC) has a 3-Year RORE % of 28.62 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Redcare Pharmacy NV and its competitors. According to the industry distribution chart, Redcare Pharmacy NV ranks #141 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 23.2%.
Is Redcare Pharmacy NV's 3-Year RORE % too high?
Redcare Pharmacy NV's current 3-Year RORE % is 28.62. The Healthcare Providers & Services industry median 3-Year RORE % is 0.74. Redcare Pharmacy NV's value of 28.62 is 3767.6% above this industry median. Based on the distribution chart, Redcare Pharmacy NV ranks #141 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's 3-Year RORE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #141 out of 607 companies for 3-Year RORE %. This places Redcare Pharmacy NV in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.74. Redcare Pharmacy NV's value of 28.62 is 3767.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.74, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redcare Pharmacy NV's current 3-Year RORE % of 28.62 is 3767.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Redcare Pharmacy NV and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current 3-Year RORE % is 28.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current 3-Year RORE % is 28.62 and 3767.6% above the Healthcare Providers & Services industry median of 0.74. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current 3-Year RORE % is 28.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for XSWX:RDC:

  • 3-Year RORE %: 28.62
  • GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
  • GF Score™: 48/100 with 2 warning signs
  • Industry Position: 3767.6% above the Healthcare Providers & Services median (#141 of 607)

No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score

Get the complete analysis for XSWX:RDC

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF60.95
Price
CHF143.20
GF Value